Top

Current Hypertension Reports

Published in:

01-10-2019 | Hypertension | Resistant Hypertension (L Drager, Section Editor)

The Potential of mHealth Applications in Improving Resistant Hypertension Self-Assessment, Treatment and Control

Authors: Karla Santo, Julie Redfern

Published in: Current Hypertension Reports | Issue 10/2019

Abstract

Purpose of Review

To review the evidence supporting the use of mobile health (mHealth) apps to improve resistant hypertension self-assessment, treatment and control.

Recent Findings

mHealth apps have been used to directly measure blood pressure (BP) levels, either using the oscillometric method with automated inflatable cuffs or using pulse wave signals detected by smartphone technology without the need for cuffs. These app-based BP monitors tend to over or underestimate BP levels when compared to a gold standard aneroid sphygmomanometer. However, the differences in BP measurements are within the acceptable range of 5 mmHg pre-defined by the European Society of Hypertension International Protocol Revision 2010. mHealth apps are also used as tools to support physicians in improving hypertension treatment. App-based clinical decision support systems are innovative solutions, in which patient information is entered in the app and management algorithms provide recommendations for hypertension treatment. The use of these apps has been shown to be feasible and easily integrated into the workflow of healthcare professionals, and, therefore particularly useful in resource-limited settings. In addition, apps can be used to improve hypertension control by facilitating regular BP monitoring, communication between patients and health professionals, and patient education; as well as by reinforcing behaviours through reminders, including medication-taking and appointment reminders. Several studies provided evidence supporting the use of apps for hypertension control. Although some of the results are promising, there is still limited evidence on the benefits of using such mHealth tools, as these studies are relatively small and with a short-term duration.

Summary

Recent research has shown that mHealth apps can be beneficial in terms of improving hypertension self-assessment, treatment and control, being especially useful to help differentiate and manage true and pseudo-resistant hypertension. However, future research, including large-scale randomised clinical trials with user-centred design, is crucial to further evaluate the potential scalability and effectiveness of such mHealth apps in the resistant hypertension context.

Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6.CrossRef

Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50. https://doi.org/10.1161/circulationaha.115.018912 [published Online First: 2016/08/10].CrossRefPubMedPubMedCentral

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRefPubMed

Carey Robert M, Calhoun David A, Bakris George L, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53–90. https://doi.org/10.1161/HYP.0000000000000084.CrossRefPubMed

Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–40. https://doi.org/10.1161/CIRCRESAHA.118.313220.CrossRefPubMed

Whelton Paul K, Carey Robert M, Aronow Wilbert S, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. https://doi.org/10.1161/HYP.0000000000000065.CrossRefPubMed

• mHealth: New horizons for health through mobile technologies: second global survey on eHealth. Switzerland: World Health Organization; 2011. Available from: http://www.who.int/goe/publications/goe_mhealth_web.pdf Accessed 20 October 2017. A review about the potential of mHealth.

Ali EE, Chew L, Yap KY-L. Evolution and current status of mhealth research: a systematic review. BMJ Innov. 2016;2(1):33–40. https://doi.org/10.1136/bmjinnov-2015-000096.CrossRef

Measuring the Information Society Report. Geneva, Switzerland: International Telecommunication Union; 2017. Available from: https://www.itu.int/en/ITU-D/Statistics/Documents/publications/misr2017/MISR2017_Volume1.pdf Accessed 4 Dec 2017.

10.

mHealth—use of appropriate digital technologies for public health: World Health Organization; 2018. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_20-en.pdf Accessed 02 June 2019.

11.

Number of apps available in leading app stores as of 1st quarter 2019. 2019. Available from: https://www.statista.com/statistics/276623/number-of-apps-available-in-leading-app-stores/ Accessed 06 June 2019.

12.

mHealth App Economics 2017—current status and future trends in mobile health Berlin, Germany: Research2Guidance; 2017. Available from: https://www.uzelf.org/wp-content/uploads/2017/12/R2G-mHealth-Developer-Economics-2017-Status-And-Trends.pdf Accessed 06 June 2019.

13.

• Roth VJ. The mHealth conundrum: smartphones & mobile medical apps—how much FDA medical device regulation is required? NC JOLT. 2014;15(3):359–424. A review describing a classification of mHealth apps into information, diagnostic, control and adapter apps.

14.

• Glynn L, Casey M, Walsh J, et al. Patients’ views and experiences of technology based self-management tools for the treatment of hypertension in the community: a qualitative study. BMC Fam Pract. 2015;16:119. https://doi.org/10.1186/s12875-015-0333-7. A qualitative study on the patients’/users’ perspectives of mHealth interventions for hypertension.

15.

• Morrissey EC, Glynn LG, Casey M, et al. New self-management technologies for the treatment of hypertension: general practitioners' perspectives. Fam Pract. 2018;35(3):318–22. https://doi.org/10.1093/fampra/cmx100. A qualitative study on the physicians’ perspectives of mHealth interventions for hypertension.

16.

• Shang F, Zhu Y, Zhu Z, et al. Validation of the iHealth BP5 wireless upper arm blood pressure monitor for self-measurement according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2013;18(5):278–81. https://doi.org/10.1097/MBP.0b013e3283638f04. A validation study of an app-based blood pressure monitor (iHealth BP5 model).CrossRefPubMed

17.

• Wang Q, Zhao H, Chen W, et al. Validation of the iHealth BP7 wrist blood pressure monitor, for self-measurement, according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2014;19(1):54–7. https://doi.org/10.1097/mbp.0000000000000017 [published Online First: 2013/12/24]. A validation study of an app-based blood pressure monitor (iHealth BP7 model).CrossRefPubMed

18.

• Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, et al. Validation in the general population of the iHealth track blood pressure monitor for self-measurement according to the European Society of Hypertension International Protocol Revision 2010: Descriptive Investigation. JMU. 2019;7(3):e13137. https://doi.org/10.2196/13137 [published Online First: 2019/03/20]. A validation study of an app-based blood pressure monitor (iHealth Track model).

19.

• Topouchian J, Agnoletti D, Blacher J, et al. Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol. Vasc Health Risk Manag. 2014;10:33–44. https://doi.org/10.2147/vhrm.s53968 [published Online First: 2014/01/31]. A validation study of an app-based blood pressure monitor (Withings BP-800).

20.

Wu H, Wang B, Zhu X, et al. A new automatic blood pressure kit auscultates for accurate reading with a smartphone: a diagnostic accuracy study. Medicine. 2016;95(32):e4538. https://doi.org/10.1097/MD.0000000000004538.CrossRefPubMedPubMedCentral

21.

•• Treskes RW, Wolterbeek R, van der Velde ET, et al. Comparison of the diagnostic accuracy of four smartphone-compatible blood pressure monitors in post-myocardial infarction patients. J Telemed Telecare. 2018;24(6):404–9. https://doi.org/10.1177/1357633X17704092. A comparison study of 4 app-based blood pressure monitors (Withings Wireless Blood Pressure Monitor, iHealth BP5, iHealth BP7, QardioArm).

22.

•• Plante TB, Urrea B, MacFarlane ZT, et al. Validation of the instant blood pressure smartphone app. JAMA Intern Med. 2016;176(5):700–2. https://doi.org/10.1001/jamainternmed.2016.0157 [published Online First: 2016/03/05]. A study evaluating the accuracy of the Instant Blood Pressure app.CrossRefPubMedPubMedCentral

23.

•• Chandrasekhar A, Kim C-S, Naji M, et al. Smartphone-based blood pressure monitoring via the oscillometric finger-pressing method. Sci Transl Med. 2018;10(431):eaap8674. https://doi.org/10.1126/scitranslmed.aap8674 . A study reporting the development of a mHealth app to measure blood pressure without an inflatable cuff.CrossRefPubMedPubMedCentral

24.

Raghu A, Praveen D, Peiris D, et al. Engineering a mobile health tool for resource-poor settings to assess and manage cardiovascular disease risk: SMARThealth study. BMC Med Inform Decis Mak. 2015;15:36. https://doi.org/10.1186/s12911-015-0148-4 [published Online First: 2015/05/01].

25.

Praveen D, Patel A, Raghu A, et al. SMARTHealth India: development and field evaluation of a mobile clinical decision support system for cardiovascular diseases in rural India. JMU. 2014;2(4):e54. https://doi.org/10.2196/mhealth.3568 [published Online First: 2014/12/10].CrossRefPubMedPubMedCentral

26.

•• Peiris D, Praveen D, Mogulluru K, et al. SMARThealth India: a stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India. PloS One. 2019;14(3):e0213708. https://doi.org/10.1371/journal.pone.0213708 [published Online First: 2019/03/27]. SmartHealth trial - A cluster randomised clinical trial evaluating an app-based clinical decision support tool to improve hypertension treatment and cardiovascular disease management in India.CrossRefPubMedPubMedCentral

27.

•• Silveira DV, Marcolino MS, Machado EL, et al. Development and evaluation of a mobile decision support system for hypertension management in the primary care setting in Brazil: mixed-methods field study on usability, feasibility, and utility. JMU. 2019;7(3):e9869. https://doi.org/10.2196/mhealth.9869 [published Online First: 2019/03/26]. TeleHAS - A study evaluating the usability of an app for clinical decision support for family physicians to improve hypertension treatment in Brazil.CrossRefPubMedPubMedCentral

28.

•• Kumar N, Khunger M, Gupta A, et al. A content analysis of smartphone-based applications for hypertension management. JASH. 2015;9(2):130–6. https://doi.org/10.1016/j.jash.2014.12.001. A content-analysis review of mHealth apps for hypertension management available in the app stores in USA.CrossRefPubMed

29.

• Hui CY, Creamer E, Pinnock H, et al. Apps to support self-management for people with hypertension: content analysis. JMU. 2019;7(6):e13257. https://doi.org/10.2196/13257 [published Online First: 2019/06/05]. A content-analysis review of mHealth apps for hypertension self-management available in the app stores in the UK.CrossRefPubMedPubMedCentral

30.

• Alessa T, Hawley MS, Hock ES, et al. Smartphone apps to support self-management of hypertension: review and content analysis. JMU. 2019;7(5):e13645. https://doi.org/10.2196/13645 [published Online First: 2019/05/30]. Another content-analysis review of mHealth apps for hypertension self-management available in the app stores in the UK.CrossRefPubMedPubMedCentral

31.

Santo K, Richtering SS, Chalmers J, Thiagalingam A, Chow CK, Redfern J. Mobile phone apps to improve medication adherence: a systematic stepwise process to identify high-quality apps. JMU. 2016;4(4):e132. https://doi.org/10.2196/mhealth.6742.CrossRefPubMedPubMedCentral

32.

Mann DM, Kudesia V, Reddy S, et al. Development of DASH mobile: a mHealth lifestyle change intervention for the management of hypertension. Stud Health Technol Inform. 2013;192:973.

33.

Carrera A, Pifarre M, Vilaplana J, et al. BPcontrol. A mobile app to monitor hypertensive patients. Appl Clin Inform. 2016;7(4):1120–34.CrossRefPubMedPubMedCentral

34.

Ashoorkhani M, Bozorgi A, Majdzadeh R, Hosseini H, Yoonessi A, Ramezankhani A, et al. Comparing the effectiveness of the BPMAP (blood pressure management application) and usual care in self-management of primary hypertension and adherence to treatment in patients aged 30-60 years: study protocol for a randomized controlled trial. Trials. 2016;17(1):511.

35.

Jha D, Gupta P, Ajay VS, et al. Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India. BMJ Open. 2017;7(8):e014851. https://doi.org/10.1136/bmjopen-2016-014851.CrossRefPubMedPubMedCentral

36.

Morawski K, Ghazinouri R, Krumme A, et al. Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. JAMA Intern Med. 2018;178(6):802–9. https://doi.org/10.1001/jamainternmed.2018.0447 [published Online First: 2018/05/02].CrossRefPubMedPubMedCentral

37.

• Bengtsson U, Kjellgren K, Hallberg I, et al. Improved blood pressure control using an interactive mobile phone support system. J Clin Hypertens (Greenwich). 2016;18(2):101–8. https://doi.org/10.1111/jch.12682. A pre-post design study evaluating a self-management support app to improve blood pressure control.

38.

• Ciemins EL, Arora A, Coombs NC, et al. Improving blood pressure control using smart technology. Telemedicine journal and e-health : the official journal of the American. Telemed J E Health. 2018;24(3):222–8. https://doi.org/10.1089/tmj.2017.0028. A pre-post design study evaluating a mHealth app to improve blood pressure control.CrossRefPubMed

39.

• Kang H, Park H-A. A mobile app for hypertension management based on clinical practice guidelines: development and deployment. JMU. 2016;4(1):e12. https://doi.org/10.2196/mhealth.4966. A pre-post design study evaluating a hypertension management app to improve medication adherence.

40.

• Patel S, Jacobus-Kantor L, Marshall L, Ritchie C, Kaplinski M, Khurana PS, et al. Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. J Diabetes Sci Technol. 2013;7(3):630–9. A pre-post design study evaluating a mHealth app to improve blood pressure control and medication adherence.CrossRefPubMedPubMedCentral

41.

• Toro-Ramos T, Kim Y, Wood M, et al. Efficacy of a mobile hypertension prevention delivery platform with human coaching. J Hum Hypertens. 2017;31(12):795–800. https://doi.org/10.1038/jhh.2017.69. A pre-post design study evaluating the Hypertension Prevention Program app to improve blood pressure control.CrossRefPubMed

42.

•• Albini F, Xiaoqiu L, Torlasco C, et al. An ICT and mobile health integrated approach to optimize patients’ education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment (POST) pilot study. Conference proceedings : Annual International. Conf Proc IEEE Eng Med Biol Soc. 2016;2016:517–20. https://doi.org/10.1109/EMBC.2016.7590753. A randomised clinical trial evaluating the EuroHypertension app to improve blood pressure control in Italy.

43.

•• Kim JY, Wineinger NE, Steinhubl SR. The influence of wireless self-monitoring program on the relationship between patient activation and health behaviors, medication adherence, and blood pressure levels in hypertensive patients: a substudy of a randomized controlled trial. J Med Internet Res. 2016;18(6):e116. https://doi.org/10.2196/jmir.5429. A randomised clinical trial evaluating the HealthCycles app to improve blood pressure control and medication adherence in USA.

44.

•• Najafi Ghezeljeh T, Sharifian S, Nasr Isfahani M, et al. Comparing the effects of education using telephone follow-up and smartphone-based social networking follow-up on self-management behaviors among patients with hypertension. Contemp Nurse. 2018;54(4–5):362–73. https://doi.org/10.1080/10376178.2018.1441730. A randomised clinical trial evaluating the Medisafe app to improve blood pressure control and medication adherence in USA.

45.

Bloss CS, Wineinger NE, Peters M, Boeldt DL, Ariniello L, Kim JY, et al. A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensors. PeerJ. 2016;4:e1554–e54. https://doi.org/10.7717/peerj.1554.CrossRefPubMedPubMedCentral

46.

•• Mobile medical applications—guidance for industry and Food and Drug Administration staff: US Food and Drug Administration; 2015 [updated 9 February 2015]. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf Archived by WebCite® at http://www.webcitation.org/6kqtH9qBw Accessed 16 Dec 2017. A randomised clinical trial evaluating an intervention delivered via the Telegram app to improve hypertension selfmanagement behaviours in Iran.

47.

•• Clinical and Patient Decision Support Software Draft Guidance for Industry and Food and Drug Administration Staff: U.S. Food and Drug Administration; 2017. Available from: https://www.fda.gov/media/109618/download Accessed 07 June 2019. A document from the FDA providing guidance on the regulations on mHealth apps.

48.

• Larson RS. A path to better-quality mHealth apps. JMU. 2018;6(7):e10414. https://doi.org/10.2196/10414. A more recent document from the FDA providing guidance on the regulations on clinical decision support systems.

49.

Byambasuren O, Sanders S, Beller E, et al. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digit Med. 2018;1(1):12. https://doi.org/10.1038/s41746-018-0021-9.

Title: The Potential of mHealth Applications in Improving Resistant Hypertension Self-Assessment, Treatment and Control
Authors: Karla Santo
Julie Redfern
Publication date: 01-10-2019
Publisher: Springer US
Keywords: Hypertension
Hypertension
Published in: Current Hypertension Reports / Issue 10/2019
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-019-0986-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 10/2019

Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension

Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease

New Molecules for Treating Resistant Hypertension: a Clinical Perspective

Opportunities to Leverage Telehealth Approaches Along the Hypertension Control Cascade in Sub-Saharan Africa

Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review

Alcohol and Hypertension—New Insights and Lingering Controversies

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials